PRINCETON, N.J.--(BUSINESS WIRE)--Endovalve, Inc., a cardiovascular device company developing the first valve-replacement system to treat mitral regurgitation, has added two top heart surgeons to its scientific advisory board (SAB), bringing the number of board members to seven.
